Kimberly Dodd

Dean, College of Veterinary Medicine Michigan State University

  • East Lansing MI

Kimberly Dodd is an internationally recognized expert in laboratory diagnostics and outbreak response for emerging infectious diseases.

Contact

Michigan State University

View more experts managed by Michigan State University

Biography

Kimberly Dodd is an internationally recognized expert in laboratory diagnostics and outbreak response for emerging infectious diseases. While director of the USDA APHIS reference laboratory for foreign animal diseases, she expanded U.S. preparedness to rapidly detect high consequence animal diseases and developed a nationwide graduate training program to train new laboratory diagnosticians. Dodd also has worked extensively in Africa to strengthen laboratory and surveillance capacity for zoonotic disease threats. She is a champion for the critical role veterinary diagnostic laboratories play in protecting public and animal health locally, nationally, and globally and is passionate about supporting the development of the next generation of veterinarians and laboratorians.

Industry Expertise

Veterinary

Areas of Expertise

College of Veterinary Medicine
Foreign Animal Diseases
Infectious Diseases
Public Health
Animal Disease
Zoonotic Diseases
Outbreak Responses
Laboratory Diagnostics
Emerging Diseases
Vaccine Development
Disease Pathogenesis

Accomplishments

Young Alumna Award, UC Davis Alumni Association

2021

Administrator's Award, USDA APHIS

2020

Market and Regulatory Program Undersecretary's Award, USDA

2020

Show All +

Education

University of California-Davis

DVM

Small Animal Medicine

University of California-Davis

Ph.D.

Comparative Pathology

University of Virginia

M.S.

Disease Ecology and Population Biology

Show All +

Affiliations

  • Centers for Disease Control and Prevention : Guest Researcher, Viral Special Pathogens Branch, 2009 - 2013
  • Metabiota : Senior Scientist, Special Projects, 2015 - 2017

News

Ask the Expert: COVID cases in animals

MSU Today  online

2021-10-19

Early in the pandemic, Michigan State University's College of Veterinary Medicine shared what was known at that time about animals and SARS-CoV-2, the virus that causes COVID-19 in humans. With the Delta variant’s spread and additional reports of SARS-CoV-2 infections in animals, Kimberly Dodd, director of the MSU Veterinary Diagnostic Laboratory, revisits the topic and provides updates as new cases are discovered.

View More

New director of MSU Veterinary Diagnostic Laboratory named

MSU Today  online

2021-08-31

“During my time as the director of a federal reference laboratory, I saw firsthand the extraordinary contributions of academic veterinary diagnostic laboratories in support of animal and public health,” Dodd said. “The MSU VDL is a leader in the field, with exceptional faculty and staff, and I look forward to leading the VDL and supporting an expansion of its mission and impact — locally, nationally and globally.”

View More

Ask the expert: Update on highly pathogenic avian influenza

MSU Today  online

2025-01-17

In April 2024, shortly after HPAI was detected in dairy cattle in several states including Michigan, Dodd answered questions about what the public should know about avian influenza and the role of the MSU laboratory. Here, she shares the latest information about the currently circulating HPAI virus, classified as H5N1, and answers new questions.

View More

Patents

Rift valley fever virus replicon particles and use thereof

WO2013192144A2

2013

(with Brian H. Bird, Cesar G. Albarino and Stuart T. Nichol)

Disclosed herein is a robust system for the reverse genetics generation of a Rift Valley fever (RVF) virus replicon particle (VRPRVF) vaccine candidate. VRPRVF can actively synthesize viral RNA and proteins, but lack structural glycoprotein genes, preventing spread within immunized individuals and reducing the risk of vaccine-induced pathogenicity. Is it disclosed herein that VRPRVF immunization is both safe and efficacious, resulting in a robust immune response that is protective against RVF virus challenge within 24 hours of immunization. Provided herein are VRPRVF, methods of producing VRPRVF, and method of using VRPRVF for immunization against RVF virus infection.

View more

Journal Articles

Evaluation of oral fluid as an aggregate sample for early detection of African swine fever virus using four independent pen-based experimental studies

Transboundary and Emerging Diseases

Kalhari Goonewardene, Chungwon J Chung, Melissa Goolia, Leslie Blakemore, Andrew Fabian, Fawzi Mohamed, Charles Nfon, Alfonso Clavijo, Kimberly A Dodd, Aruna Ambagala

2021

The sustained spread of African swine fever (ASF) virus throughout much of the world has made ASF a global animal health priority, with an increased emphasis on enhancing preparedness to prevent, detect and respond to a potential outbreak of ASF virus (ASFV).

View more

Outbreak of rabbit hemorrhagic disease virus 2 in the southwestern United States: first detections in southern California

Journal of Veterinary Diagnostic Investigation

Javier Asin, Akinyi C Nyaoke, Janet D Moore, Viviana Gonzalez-Astudillo, Deana L Clifford, Emma L Lantz, Andrea B Mikolon, Kimberly A Dodd, Beate Crossley, Francisco A Uzal

2021

An outbreak of rabbit hemorrhagic disease virus 2 (RHDV2)-associated disease occurred in the southwestern United States following its first detection in New Mexico in March 2020.

View more

Coding-Complete Genome Sequences of Emerging Rabbit Hemorrhagic Disease Virus Type 2 Isolates Detected in 2020 in the United States

Microbiology Resource Announcements

VK O’Donnell, L Xu, K Moran, F Mohamed, T Boston, SJ Pauszek, DA Vierra, B Faburay, KA Dodd, RW Barrette

2021

Five rabbit hemorrhagic disease virus type 2 (RHDV2) coding-complete genome sequences were obtained from the livers of domestic and wild rabbits during the 2020 outbreak in the United States. These represent the first available RHDV2 sequences from the United States.

View more

Show All +